glutamic acid has been researched along with Hematologic Malignancies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, Q; Du, J; Li, Z; Liu, Y; Meline, B; Ranheim, E; Ryu, MJ; Tan, LX; Wang, J; Wang, Z; Young, KH; Zhang, J | 1 |
1 other study(ies) available for glutamic acid and Hematologic Malignancies
Article | Year |
---|---|
Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner.
Topics: Amino Acid Substitution; Animals; Aspartic Acid; Bone Marrow Transplantation; Cell Transformation, Neoplastic; Female; Gene Dosage; Genes, ras; Glutamic Acid; Hematologic Neoplasms; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Oncogenes; Organ Specificity | 2011 |